BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15760617)

  • 1. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease.
    Jellinger KA; Attems J
    J Neurol Sci; 2005 Mar; 229-230():37-41. PubMed ID: 15760617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
    Jellinger KA; Attems J
    Acta Neurol Scand; 2006 Jul; 114(1):38-46. PubMed ID: 16774626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
    Attems J; Jellinger KA
    Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study.
    Jellinger KA; Mitter-Ferstl E
    J Neurol; 2003 Sep; 250(9):1050-5. PubMed ID: 14504965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.
    Jellinger KA
    Neurodegener Dis; 2010; 7(1-3):112-5. PubMed ID: 20173339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J; Lintner F; Jellinger KA
    Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study.
    Jellinger KA; Attems J
    Acta Neuropathol; 2003 Jan; 105(1):14-7. PubMed ID: 12471455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology.
    Attems J; Quass M; Jellinger KA; Lintner F
    J Neurol Sci; 2007 Jun; 257(1-2):49-55. PubMed ID: 17306303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease and cerebrovascular pathology: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.
    Attems J; Quass M; Jellinger KA
    Acta Neuropathol; 2007 Jan; 113(1):53-62. PubMed ID: 17031655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Alzheimer and vascular lesion thresholds for mixed dementia.
    Gold G; Giannakopoulos P; Herrmann FR; Bouras C; Kövari E
    Brain; 2007 Nov; 130(Pt 11):2830-6. PubMed ID: 17878206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral amyloid angiopathy and dementia.
    Tian J; Shi J; Mann DM
    Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the pathology of vascular cognitive impairment.
    Jellinger KA
    J Neurol Sci; 2005 Mar; 229-230():57-63. PubMed ID: 15760620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease.
    Nakata-Kudo Y; Mizuno T; Yamada K; Shiga K; Yoshikawa K; Mori S; Nishimura T; Nakajima K; Nakagawa M
    Dement Geriatr Cogn Disord; 2006; 22(1):8-14. PubMed ID: 16645275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular pathologies and cognition in a population-based cohort of elderly people.
    Fernando MS; Ince PG;
    J Neurol Sci; 2004 Nov; 226(1-2):13-7. PubMed ID: 15537512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.